Development of Psycho-Oncology telehealth recommendations

ABSTRACT

Aims: The COVID-19 pandemic triggered rapid implementation of telephone and videoconference telehealth across Australia. The Psycho-Oncology Cooperative Research Group (PoCoG) investigated the barriers and enablers to wider implementation post pandemic. Psychologists working in oncology face unique challenges such as working with patients experiencing existential issues and report inadequate training in conducting telehealth psychology. This research aimed to address the paucity of evidence available to guide adaption of therapy to telehealth through the development of evidence-based consensus recommendations for Psycho-oncology . Methods: Content for the recommendations was developed based on a review of the psychology and Psycho-Oncology literature and stakeholder feedback through an expert advisory group (n = 14) comprising clinical psychology, Psycho-Oncology and health communication/education experts, guiding the focus of the content. The compilation of recommendations involved an iterative co-design process. Clinical scenarios, self-reflection exercises and clinical guidance were incorporated to facilitate clinical relevance. The relative importance of content topics was assessed based on a Delphi consensus process that is ongoing. Results: The co-design approach identified key recommendations;(1) adaptations to therapeutic techniques, (2) clinical/practical strategies (including worksheets and case studies), (3) communication challenges, (4) maintaining the therapeutic alliance, and (5) managing patient presentations. A national Delphi consensus process involving clinical psychologists working in oncology is ongoing and will guide further refinement of the educational resource. Conclusions: These recommendations fill an identified gap in the literature and provide a robust expert-endorsed document to guide clinicians through telehealth in the Psycho-Oncology field. This will support an increase in sustainability of, and confidence in, Psycho-Oncology telehealth moving forward.